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Abstract
Background: We conducted a surveillance study to determine the leading causes of bloodstream infection in febrile
patients seeking treatment at three district hospitals in Pemba Island, Zanzibar, Tanzania, an area with low malaria
transmission.
Methods: All patients above two months of age presenting to hospital with fever were screened, and blood was collected
for microbiologic culture and malaria testing. Bacterial sepsis and malaria crude incidence rates were calculated for a one-
year period and were adjusted for study participation and diagnostic sensitivity of blood culture.
Results: Blood culture was performed on 2,209 patients. Among them, 166 (8%) samples yielded bacterial growth; 87 (4%)
were considered as likely contaminants; and 79 (4%) as pathogenic bacteria. The most frequent pathogenic bacteria isolated
were Salmonella Typhi (n = 46; 58%), followed by Streptococcus pneumoniae (n = 12; 15%). The crude bacteremia rate was 6/
100,000 but when adjusted for potentially missed cases the rate may be as high as 163/100,000. Crude and adjusted rates
for S. Typhi infections and malaria were 4 and 110/100,000 and 4 and 47/100,000, respectively. Twenty three (51%), 22 (49%)
and 22 (49%) of the S.Typhi isolates were found to be resistant toward ampicillin, chloramphenicol and cotrimoxazole,
respectively. Multidrug resistance (MDR) against the three antimicrobials was detected in 42% of the isolates.
Conclusions: In the presence of very low malaria incidence we found high rates of S. Typhi and S. pneumoniae infections on
Pemba Island, Zanzibar. Preventive measures such as vaccination could reduce the febrile disease burden.
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Introduction
For decades, falciparum malaria has been the leading cause of
febrile illness among patients in sub-Saharan Africa presenting to
hospitals for treatment. However, during the last ten years, there
has been a decline in malaria in many parts of sub-Saharan Africa
[1,2,3,4]. Little information exists about the current leading causes
of severe febrile illness in areas of sub-Saharan Africa where
malaria control strategies have been deployed. Limited diagnostic
facilities have led to a lack of data on community-acquired invasive
bacterial infection [5]. Recent reviews have tried to overcome this
problem by aggregating available information on bloodstream
infections [6] and extrapolating incidence rates [7]. But these are
limited by the diversity of the continent and its populations. More
site-specific and detailed information on invasive bacterial
infections is required to improve the prevention and management
of febrile illnesses in the region.
Following the deployment of artemisinin-based combination
therapy starting in late 2003 and the programmatic distribution of
long-lasting insecticidal nets from early 2006 in Zanzibar,
Tanzania, malaria-associated morbidity and mortality has de-
creased dramatically [8,9]. We conducted a surveillance study to
determine the leading causes of bloodstream infections in febrile
patients seeking treatment at district hospitals in Pemba Island,
Zanzibar, and calculated incidence rates for the major pathogens
isolated.
Materials and Methods
Ethics
The study was conducted according to the principles expressed
in the Declaration of Helsinki. Written informed consent was
obtained from all study participants or their legal guardians. The
Zanzibar Medical Research and Ethics Committee and the
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International Vaccine Institute - Institutional Review Board in
South Korea approved this project.
Study site and population
The study was conducted on Pemba, one of the main islands of
the Zanzibar archipelago (Figure 1). The total area of Pemba is
approximately 984 square kilometres and much of its terrain is
hilly, heavily vegetated, and poorly accessible through mainly
unpaved roads. The northern region of Pemba is divided into
Micheweni and Wete districts, while the southern region is divided
into Mkoani and Chake-Chake districts. The administrative center
is Chake-Chake, which is located in the district of the same name.
In 2010, the population of Pemba was estimated to be 500,600
with more than 50% of the population below the age of 15 years
[10,11].
Pemba is mainly rural, with an economy based on fishing,
seaweed harvesting, and the farming of cloves, coconut, and copra.
Primary health care is delivered through 58 primary health care
units (PHCU) that provide minor services and can admit one to
two inpatients. The units have limited dispensaries but usually
have no doctors or laboratory facilities. Patients that require
secondary health care are referred to one of the three district
hospitals: Chake Chake, Wete, or Mkoani. Additionally, there are
the Vitongoji and Micheweni cottage hospitals, which are mainly
used during outbreaks of diarrheal diseases.
The Zanzibari Expanded Programme of Immunization (EPI)
includes the following vaccines: Bacille Calmette-Gue´rin (BCG),
live oral polio, diphtheria-whole cell pertussis-tetanus-hepatitis B,
and the monovalent measles vaccines for children, as well as the
supplemental tetanus toxoid vaccine for women of child-bearing
age. Haemophilus influenzae type b and pneumococcal vaccines are
currently not included in the EPI. Typhoid vaccine is not routinely
administered in Zanzibar.
Study procedures
The study was implemented in phases. Surveillance was started
first at Chake Chake District Hospital in March 2009, followed by
Mkoani District Hospital in May 2009, and Wete District Hospital
in August 2009 (Figure 1). Surveillance was continued in all three
hospitals until the end of December 2010. Clinical information
was recorded on a standard digital case record form using
handheld computers, also known as personal digital assistants
(PDAs) [12]. Treatment was provided for patients according to
national guidelines.
Patients presenting for care during the study period were
screened for eligibility. Subjects above the age of 2 months with a
recorded temperature of $37.5uC (tympanic thermometer)
presenting at the outpatient department (OPD) or subjects above
the age of 2 months admitted to a hospital with any history of fever
were included in the study. Study staff screened all patients at the
OPD during opening hours from 08:00 to 13:00, Monday to
Friday. Eligible patients were referred to the study nurse for
informed consent, enrolment and blood collection, while waiting
to see the hospital health worker who prescribed additional
diagnostic tests and treatment, or admitted the patient to the ward.
Patients who did not present with a documented temperature of
$37.5uC but with a history of fever were later enrolled into the
study if admitted to the ward. Enrolment of inpatients into the
study was conducted in the afternoon after closure of the OPD.
Patients admitted during the early evening and night, were
screened for eligibility the following morning.
Point-of-care and laboratory investigations
We collected 1 to 8 millilitres of blood from children and 9 to 12
millilitres from adults. Immediate bedside testing was done for
hemoglobin and glucose (Hemocue, Anlkholm Sweden). About 1–
3 ml of blood from children and 8–10 ml from adults were used to
Figure 1. Study site.
doi:10.1371/journal.pone.0030350.g001
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inoculate pediatric and adult BACTEC bottles (Peds Plus Aerobic
and Plus Aerobic; BD, USA), respectively, and incubated in an
automated blood culture machine (BACTEC 9050, BD, USA).
Blood cultures were processed according to standard guidelines
[13]. Api20E (Biomerieux, France) was used for further identifi-
cation of gram-negative rods, which was followed by serological
confirmation for all presumptive Salmonella isolates. The remaining
blood samples were used for malaria rapid diagnostic testing
(Paracheck, Orchid Biomedical, Mumbai, India) and the prepa-
ration of thin and thick blood films. The films were Giemsa-
stained and read. At least 300 high power microscopic fields were
examined to exclude malaria.
Antimicrobial susceptibility testing was performed using the
modified Kirby-Bauer disc diffusion method and the mean
inhibitory concentration was assessed using Etest. Evaluation
was done according to the guidelines of the Clinical and
Laboratory Standards Institute [14].
Data management, definitions and analysis
Clinical data entered directly into PDAs had real-time error,
range and consistency checks, and were transferred to the central
database at regular intervals [12]. HIV test results were obtained
from hospital records if the patient consented, and were entered
into the database with no patient identifier information.
Laboratory results were recorded on paper forms and double-
entered into custom-made data entry programs using FoxPro
software (Microsoft, Seattle, Washington, USA). The de-identified
clinical data were linked to the laboratory results, using each
participant’s study identification number.
The following definitions were applied during the analysis.
Bacteremia was defined as fever with isolation of pathogenic
bacteria from blood culture. Contaminants were defined as non-
pathogenic bacteria most probably derived from the skin during
blood collection and included Bacillus spp., Corynebacterium and
coagulase-negative Staphylococci. Malaria was defined as fever with
a positive blood film and/or positive rapid diagnostic test (RDT).
In order to avoid seasonal confounding in the incidence rates,
we used data from January to December 2010 only. Incidence
rates were calculated per 100,000 persons and by age group: #5,
.5–15 and .15 years old. The total and age-specific number of
cases was used as the numerator and the respective population for
2010 projected from the 2002 census [10,11] as the denominator.
In the primary crude analysis we assumed that the surveillance
system captured all patients in Pemba with severe febrile illness
who presented to hospital from January to December 2010. Crude
incidence rates and their 95% confidence intervals (CI) were
calculated using the Wilson score method. Data on health- seeking
behaviour from four areas around Chake Chake District Hospital
showed an average use of the hospital of 10.6% for febrile patients
(Kaljee and Pach, unpublished data). In a sensitivity analysis for
bacteremia, crude rates were multiplied by a factor of 9.43 (1/
health care utilisation rate) to adjust for missed cases due to health
seeking behaviour, by a factor 1.36 (1/[1- proportion non
enrolled]) to adjust for those eligible but not proceeding to
enrolment (26.4%), by factor 1.02 and 1.04 (1/[1- proportion not
consented and insufficient blood]) to adjust for those not
consenting or were insufficient amounts of blood were collected
(2.42%, 4.01%, 1.85% and 1.50% depending on age group), as
well as by a factor of 2 (1/[1- culture sensitivity]) for an average
blood culture sensitivity of 50% [7,15,16,17,18]. In the sensitivity
analysis for malaria, crude incidence rates were multiplied by the
same factors as the bacteremia results to adjust for health seeking
behaviour (factor 9.43) and for the proportion of eligible patients
that were not enrolled (factor 1.36). In addition malaria crude
incidence rates were multiplied by a factor of 1.02, 10.4 and 10.1
depending on age group to adjust for the proportion of patients
that did not consent or had no malaria test done (total: 2.42%; #5
years: 4.29%; .5–15 years: 1.51% and .15 years: 1.44%).
All analyses were performed using Microsoft Excel spreadsheets
and Stata version 10 (StataCorp, College Station, TX, USA).
Results
A total of 142,767 patients presented for care during study
hours at the three participating hospitals and were screened for
eligibility (Figure 2). Of these, 3,105 (2%) patients were found to be
eligible. There were 821 (26%) who did not proceed to the study
nurse, 59 (2%) who refused participation, and 16 (0.5%) from
whom insufficient amounts of blood were drawn. There were no
significant differences (p.0.05) regarding sex, age or temperature
among eligible patients enrolled and eligible patients not enrolled.
Blood culture was performed on 2,209 (71%) patients and these
results were included in the analysis. Of these, 166 (8%) samples
yielded bacterial growth: 87 (4%) were considered as likely
contaminants and 79 (4%) as pathogenic bacteria. Among the
2,209 patients, RDT for malaria was done for 2,193 (99%) cases
and blood films for 2,147 (97%) cases. One (0.04%) patient had a
co-infection of bacteremia and malaria (Plasmodium falciparum),
whereas 28 (1%) had malaria (P. falciparum) with a negative blood
culture (Figure 2). Only one patient agreed to be tested for HIV
and two patients reported to have had tests done previously.
We assessed the bacteremia cases by hospital (Table 1). Of the
2,209 patients, 975 (44%) were enrolled at Chake Chake District
Hospital from 16th March 2009 to 30th December 2010; 682
(31%) at Mkoani District Hospital from 4th May 2009 to 30th
December 2010; and 552 (25%) at Wete District Hospital from 5th
August 2009 to 30th December 2010. The case fraction of
bacteremia varied significantly (p,0.01) from 2% to 5% across the
sites. Overall, the most frequent pathogenic species isolated was
Salmonella Typhi (n = 46; 58%).
Of the 2,209 patients included in the analysis, 637 (29%) were
#5 years old, 490 (22%) were.5 to 15 years old, and 1,082 (49%)
were .15 years old (Table 2). The pathogenic bacterial isolates
were ranked according to frequency and by age group (Table 2). S.
Typhi was found to be the leading pathogen in all age groups,
causing 10/29 (35%), 12/16 (75%) and 24/34 (71%) of
bacteremia, respectively and 46 cases (58%) overall. The second
most frequently isolated pathogen was Streptococcus pneumoniae,
which was responsible for 12 (15%) bacteremia cases overall; and
8/29 (28%) among those #5 years old, 3/16 (19%) among those 5
to 15 years of age and 1/34 (3%) among those .15 years. Other
commonly isolated bacterial pathogens were Escherichia coli,
Staphylococcus aureus, and Haemophilus influenzae type b (Hib).
We calculated the crude and adjusted incidence rates for
bacteremia (Table 3) and falciparum malaria (Table 4). The crude
incidence rate for invasive bacteremia was 6 per 100,000 (95%CI:
4 to 9) persons per year (Table 3). Adjustments yielded an
incidence rate of 163/100,000 (95%CI: 152 to 174) with a rate of
146/100,000 (95%CI: 127 to 169) for children less than 6 years
old, 162/100,000 (95%CI: 142 to 186) for those 6 to 15 years old
and 171/100,000 (95%CI; 155 to 188) for those above 15 years of
age. No significant differences between age groups were found
(p.0.05).
The leading pathogen, S. Typhi, had a crude incidence rate of
4/100,000 (95%CI: 3 to 6) and an adjusted rate of 110/100,000
(95%CI: 102 to 120). The age-specific incidence rates of typhoid
fever increased with age (Table 3). S. pneumoniae rates were highest
among children below 15 years of age (Table 3). The crude
Bacterial Infections in Zanzibar
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invasive bacteremia rates in female patients and male patients
were 7/100,000 (95%CI: 4 to 11) and 6/100,000 (95%CI: 3 to
10), respectively. The crude typhoid fever rate in females was 5/
100,000 (95%CI: 3 to 9) and in males was 3/100,000 (95%CI: 2 to
6) (p.0.05).
The overall crude incidence rate of falciparum malaria was 4/
100,000 (95%CI: 2 to 6) and 1/100,000 (95%CI: 0.2 to 2) if only
slide-positive cases were included in the analysis (Table 4).
Adjustments yielded rates of 47/100,000 (95%CI: 42 to 54) and
8/100,000 (95%CI: 6 to 11), respectively. Age-specific adjusted
Figure 2. Assembly of patients in the study.
doi:10.1371/journal.pone.0030350.g002
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rates were highest in the youngest age group and showed statistical
difference (p,0.01) (Table 4).
Antibiotic susceptibility was assessed for 45/46 (98%) S.Typhi
isolates (Table 5) and for all S. pneumoniae, E. coli, S.aureus, and Hib
isolates (Table 6). Twenty three (51%), 22 (49%) and 22 (49%) of
the S.Typhi isolates were found to be resistant to ampicillin,
chloramphenicol and cotrimoxazole, respectively. One isolate was
found to be resistant to ciprofloxacin. Multidrug resistance (MDR)
against the three first-line antimicrobials was detected in 19/45
(42%) isolates. Out of these 19 MDR isolates, four (21%) were
resistant to nalidixic acid, but none of them was resistant to
ciprofloxacin.
Discussion
We found that S. Typhi to be the leading pathogen in adults and
children presenting to hospitals with severe febrile illness in an
area of low malaria transmission. Our adjusted rate of 110 typhoid
fever cases per 100,000 population falls into the category of ‘‘high
typhoid incidence area (.100 per 100,000 population per year)’’
based on the classification by Crump et al. [7]. In accordance with
earlier findings [6], the incidence rates of blood culture-confirmed
typhoid fever cases increased with age. Higher rates were also
found among the female population, compared with the male
population, though not at a statistically significant level. S.
Table 1. Number (%) of bacteremia cases by participating hospital during the entire study period (2009–2010).
Chake Chake Mkoani Wete Total p
n (%) n (%) n (%) n (%)
Patients enrolled 975 682 552 2209
Period of surveillance 16/03/2009–30/12/2010 04/05/2009–30/12/2010 05/08/2009–30/12/2010
Pathogenic bacteria isolated 30 (3.1%) 37 (5.4%) 12 (2.2%) 79 (3.6%) 0.005
S.Typhi 20 21 5 46 0.3
(66.7%) (56.8%) (41.7%) (58.2%)
S.pneumoniae 2 5 5 12 0.02
(6.7%) (13.1%) (41.7%) (15.2%)
E.coli 4 1 0 5 0.17
(13.3%) (2.7%) (0%) (6.3%)
S.aureus 3 1 1 5 0.36
(10%) (2.7%) (8.3%) (6.3%)
Hib 1 2 0 3 1.0
(3.3%) (5.4%) (0%) (3.8%)
Others 0 7 1 8 0.03
(0%) (28.9%) (8.3%) (10.1%)
doi:10.1371/journal.pone.0030350.t001
Table 2. Age-specific ranking of pathogens during the entire study period.
#5 y
(n =637) Rank
.5 y–15 y
(n=490) Rank
.15 y
(n=1082 Rank Total no (%) Overall rank
All pathogenic bacteria 29 16 34 79
- Salmonella Typhi 10 1 12 1 24 1 46 1
(34.5%) (75%) (70.6%) (58.2%)
- S.pneumoniae 8 2 3 2 1 4 12 2
(27.6%) (18.7%) (2.9%) (15.2%)
- E.coli 0 0 5 2 5 3
(0%) (0%) (14.7%) (6.3%)
- S.aureus 2 3 1 3 2 3 5 3
(6.9%) (6.2%) (5.9%) (6.3%)
- Hib 2 3 0 1 4 3 4
(6.9%) (0%) (2.9%) (3.8%)
- other 7 0 1 8 –
(24.1%) (0%) (2.9%) (10.1%)
Contaminants 52 5 30 87
Total 81 21 64 166
doi:10.1371/journal.pone.0030350.t002
Bacterial Infections in Zanzibar
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pneumoniae was the second most frequently isolated pathogen in all
age groups.
Incidence data on community-acquired bacteremia from this
region is sparse. A study from 2006 from western Kenya reports
incidence rates of bacteremia among children below the age of 2
and below 5 years to be 1,741 and 909 per 100,000 children,
respectively [19], considerably higher than our findings. However,
the Kenya study was a community-based study that included a
demographic surveillance system, which allowed for a more
complete detection of cases than our hospital-based sentinel study.
Site-specific differences in malaria transmission may also influence
the rates and etiology of invasive bacteremia. Since malaria has
been shown to predispose to bacteremia [20], it is likely that the
main reason for the lower positivity rate is the low malaria rate in
Pemba. The dramatic reduction of malaria transmission in
Zanzibar [9], may therefore provide additional benefits for the
local population. This is supported by studies that showed that the
control of falciparum malaria in Zanzibar was associated with a
decrease in childhood mortality between 2002 and 2005 [8]. In
our study we did not isolate any non-typhoidal Salmonella.
Falciparum malaria is associated with invasive non-typhoidal
Salmonellosis and also likely accounts for these differences [21].
Reddy et al. [6] conducted a recent review of studies that used
blood culture to identify non-malaria bloodstream infections
among patients admitted to hospitals in Africa. Based on 22
studies from 1984 to 2006 and on a total of 58,296 patients, the
leading bacterial isolate was S. enterica (1,643 or 29.1%). Fifty eight
percent of these were non-typhoidal Salmonella, 34% were S.
Typhi, and 8% were unspecified S. enterica isolates. A recent study
by Crump et al found S.Typhi the leading pathogen among HIV
negative children in the Moshi area with 6 out of 341 patients [22].
We found significant differences in the isolation rate of
pathogenic bacteria among hospitals. Potential explanations for
this phenomenon might be differences in health-seeking behav-
iour. The differences were not due to outbreaks since the cases
were rather evenly distributed over the entire study period.
Table 4. Crude and adjusted incidence rates for malaria.
No. of
cases in
2010 only
Population
in
catchment
area 2010*
Crude
incidence rate
per 100,000
(95%CI) p
Health-
seeking
behaviour
(%)**
Adjusted
rate I
Did not
proceed to
study nurse
(%)
Adjusted
rate II
No consent;
no malaria
test (%)
Adjusted
incidence rate
per 100,000
(95%CI)
Malaria (RDT and/or
slide pos.) total
18 500600 4 (2 to 6) 10.6 34 26.4 46 2.42 47 (42 to 54)
Malaria (only slide) total3 500600 1 (0.2 to 2) 10.6 6 26.4 8 2.42 8 (6 to 11)
Malaria (RDT and/or
slide pos.) #5 years
10 127848 8 (4 to 14) 10.6 74 26.4 100 4.29 105 (89 to 124)
Malaria (RDT and/or
slide pos.) 5–15 years
5 128917 4 (2 to 9) 0.006 10.6 37 26.4 50 1.51 51 (40 to 64)
Malaria (RDT and/or
slide pos.) .15 years
3 243835 1 (0.4 to 4) 10.6 12 26.4 16 1.44 16 (12 to 22)
*According to projections of the national census 2002; **People attending Chake Chake Hospital by %; Kaljee and Pach, unpublished data.
doi:10.1371/journal.pone.0030350.t004
Table 5. Susceptibility patterns of S.Typhi (n = 45)*.
Resistant Intermediate Susceptible
n (%) n (%) n (%)
Ampicillin 23 (51.1%) 2 (4.4%) 20 (44.4%)
Chloramphenicol 22 (48.9%) 2 (4.4%) 21 (46.7%)
Trimethoprim-sulfamethoxazole (Cotrimoxazol) 22 (48.9%) 1 (2.2%) 22 (48.8%)
Amoxicillin/Clavulanic acid 0 (0%) 1 (2.2%) 44 (97.8%)
Cefazolin 2 (4.4%) 3 (6.7%) 40 (88.9%)
Ceftazidime 3 (6.7%) 0 (0%) 42 (93.3%)
Ceftriaxon 0 (0%) 0 (0%) 45 (100%)
Ciprofloxacin 1 (2.2%) 0 (0%) 44 (97.8%)
Gentamycin 3 (6.7%) 1 (2.2%) 41 (92.1%)
Nalidixic acid 14 (31.1%) 2 (4.4%) 29 (64.4%)
Ampicillin + Chloramphenicol + Trimethoprim-sulfamethoxazole 19 (42.2%) 0 (0%) 19 (42.2%)
Ampicillin + Chloramphenicol + Trimethoprim-sulfamethoxazole + Nalidixic acid 4 (8.9%) 0 (0%) 9 (20%)
Ampicillin + Chloramphenicol + Trimethoprim-sulfamethoxazole + Nalidixic Acid +
Ciprofloxacin
0 (0%) 0 (0%) 9 (20%)
*According to Performance Standards for Antimicrobial Susceptibility Testing, M100-S16, Vol 26. No. 3. CLSI, January 2007.
doi:10.1371/journal.pone.0030350.t005
Bacterial Infections in Zanzibar
PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e30350
With the exception of S. Typhi, all isolates were found to be
susceptible to at least one locally available antibiotic. About half of
the Salmonella Typhi isolates were resistant to at least one of the
frequently used drugs: ampicillin, chloramphenicol, and trimeth-
oprim-sulfadoxine. More than 40% showed resistance toward all
three drugs (multi-drug resistance). These are considerably higher
resistance rates than those reported between 1995 and 2008 [6].
However, more recent data from Kenya showed even higher
numbers of resistant isolates [23] and reports from Kenya warn
about rising resistance towards fluoroquinolones [24]. Although
we found low resistance towards ciprofloxacin, continued
monitoring of susceptibility patterns is essential.
The current routine treatment for inpatients with suspected
bacteremia is ampicillin and gentamicin. If this fails and subject to
availability ceftriaxone is given. For outpatients ciprofloxacin is
routinely given if bacteremia is suspected. According to our data
this strategy seems appropriate especially since full susceptibility
towards ceftriaxone was found for S.Typhi, E.coli and Hib.
This study had several limitations. Firstly, incidence calculations
were adjusted for health-seeking behaviour based on findings from
four villages around Chake Chake District Hospital only (Kaljee
and Pach, unpublished). Variations in health-seeking behaviour by
geographic distance to the hospital, sex, or age were not taken into
account. It is possible that a larger percentage than estimated
make use of the participating health care facilities during a
prolonged course of disease, if not as the first choice, then as a later
alternative. Secondly, the study period was brief and no changes in
disease trends could not be detected. Thirdly, only single blood
cultures were collected. Repeated sample collection and multiple
cultures from each patient might have increased the overall
positivity rate [25]. Also greater blood volumes may have
increased the isolation rate but this would have been difficult toe
carry-out. Finally, there was very limited information on the HIV
status of patients. We were unable to compare incidence of
bloodborne pathogens between HIV-positive and HIV-negative
patients. Previous HIV prevalence studies in Zanzibar have shown
an infection rate in the general population on both islands Pemba
and Unguja to be 0.6% in 2003 [26], suggesting a limited impact
on our findings.
In summary, in the presence of very low malaria incidence
we found high rates of typhoid fever in all age groups and
S. pneumoniae among children on Pemba Island, Zanzibar. The
data indicate the need to consider preventive strategies against
these diseases to further decrease the burden of severe febrile
illness. These include long-term improvements in education,
hygiene behaviour such as hand-washing, water supply sanita-
tion to address the high S.Typhi incidence. In addition
vaccination programmes against typhoid fever and the intro-
duction of the pneumococcal vaccine in the EPI program
deserves consideration.
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Table 6. Susceptibility patterns of S.pneumoniae, E.coli, S.aureus and Hib*.
Resistant Intermediate Susceptible
S. pneumoniae (n = 12) n (%) n (%) n (%)
Chloramphenicol 0 (0%) 0 (0%) 12 (100%)
Erythromycin 0 (0%) 0 (0%) 12 (100%)
Trimethoprim/sulfadoxin 7 (58.3%) 2 (16.7%) 3 (25%)
Penecillin 3 (25%) 0 (0%) 9 (75%)
E.coli (n = 5)
Amoxicillin/Clavulanic acid 0 (0%) 2 (40%) 3 (60%)
Ampicillin 3 (60%) 0 (0%) 2 (40%)
Cefazolin; Ceftazidime; Ceftrioxone 0 (0%) 0 (0%) 5 (100%)
Chloramphenicol; Ciprofloxacine; Gentamycin 1 (20%) 0 (0%) 4 (80%)
Nalidixic acid 2 (40%) 0 (0%) 3 (60%)
Trimethoprim/sulfadoxin 4 (80%) 0 (0%) 1 (20%)
S.aureus (n = 5)
Cefoxitin (Oxacillin); Vancomycin 0 (0%) 0 (0%) 5 (100%)
Chloramphenicol; Erythromicin 0 (0%) 1 (20%) 4 (80%)
Penicillin 4 (80%) 0 (0%) 1 (20%)
Trimethoprim/sulfadoxin 2 (40%) 0 (0%) 3 (60%)
Hib (n=3)
Ampicillin 2 (66.7%) 0 (0%) 1 (33.3%)
Ceftriaxone 0 (0%) 0 (0%) 3 (100%)
Chloramphenicol; Trimethoprim/sulfadoxin 3 (100%) 0 (0%) 0 (0%)
*According to Performance Standards for Antimicrobial Susceptibility Testing, M100-S16, Vol 26. No. 3. CLSI, January 2007.
doi:10.1371/journal.pone.0030350.t006
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